Courage Through the Crisis


Care for the Frontline Healthcare Worker as the Coronavirus Progresses

Are you worried about spreading the disease to your family? Are you ramping up to fight the virus or being placed on standby because much of your work is elective or “noncritical?” Are you fearful for the future, whether your health, your finances or your job?

If you’re asking yourself these questions and more, remember that you are not alone! CMDA is here for you for such a time as this. As a ministry for Christians in healthcare, we stand ready to pray for you, to assist you in any way we can and to offer resources to help you sustain the onslaught of extra work.

We are going to be here with you every step of the way, so check back often for the latest information and resources to help you as you fight against COVID-19.

CMDA Statement on COVID-19 and Church Gatherings

Due to the high transmissibility of the omicron variant of SARS-CoV-2 with the resultant current spike in cases of COVID-19 across the United States, CMDA recommends that if churches continue to meet in person, the church should recommend effective masks for those in attendance over the age of 2 years. Data on the transmission of the omicron variant show that when a person becomes infected with the virus, they are most likely to transmit the virus to other individuals 24 hours prior to the onset of symptoms. This means that every person that gets COVID-19 is initially an asymptomatic spreader of the infection.


Further information is available here.


CMDA Update on COVID-19 Vaccines as of March 4, 2021

Three Operation Warp Speed vaccines have received Emergency Use Authorization (EUA) from the FDA:

  1. On December 11, 2020, the FDA issued an EUA for Pfizer-BioNTech’s COVID-19 vaccine. A fact sheet on the vaccine can be found here.
    • The Pfizer-BioNTech COVID-19 vaccine is an mRNA vaccine.
    • Effectiveness of the vaccine was found to be 95 percent.
    • Approval is for individuals 16 years of age and older.
    • The vaccine is administered as a series of two doses (0.3mL each) three weeks apart.
  2. On December 18, 2020, the FDA issued an EUA for Moderna’s COVID-19 vaccine. A fact sheet on the vaccine can be found here.
    • The Moderna COVID-19 vaccine is an mRNA vaccine.
    • Effectiveness of the vaccine was found to be 94.1 percent.
    • Approval is for individuals 18 years of age and older.
    • The vaccine is administered as a series of two doses (0.5mL each) four weeks apart.
  3. On February 27, 2021, the DFA issued an EUA for the Johnson & Johnson (Janssen) vaccine. A fact sheet on the vaccine can be found here.
    • The vaccine is approved for individuals 18 years of age and older.
    • The vaccine showed 67 percent effectiveness in preventing moderate to severe COVID-19 overall in all countries studied.
    • The vaccine was 85 percent effective in preventing severe/critical COVID-19 that occurred at least 28 days post vaccination.
    • The Johnson & Johnson COVID-19 vaccine is a viral vector vaccine using an adenovirus to carry a coronavirus gene into human cells.
    • This vaccine has two advantages over the mRNA vaccines:
      1. It is a one-dose vaccine.
      2. It can be stored at refrigeration temperatures
  1. AstraZeneca’s COVID-19 vaccine has been authorized for emergency use in the United Kingdom.
    • study published in Lancet found that overall effectiveness of the vaccine was 70.4 percent.
    • The low dose/high dose regimen had an effectiveness of 90 percent.
    • The high dose/high dose regimen had an effectiveness of 62.1 percent.
    • Due to questions regarding unexpected results, AstraZeneca has not decided whether to apply to the FDA for an EUA.
  1. Novavax entered Phase 3 trials of its vaccine on December 28, 2020.
    • The Novavax vaccine is made from a stabilized form of the coronavirus spike protein combined with a proprietary adjuvant, MatrixMä.
    • The vaccine is administered in two doses, 21 days apart.
  1. On December 11, 2020, Sanofi and GSK announced a delay in their COVID-19 vaccine due to a poor immune response in adults more than 50 years of age.

Ethical Concerns

Unfortunately, research performed by The Charlotte Lozier Institute has confirmed that five of the six vaccines listed above have used one of two different fetal cell lines derived from two separate decades-old abortions to assist in the development of these new vaccines. It is still unknown whether the vaccine from Sanofi used a fetal cell line because no information regarding their vaccine development has been published.

It is important to note that fetal cell lines can be used in three different stages of vaccine development: design, confirmation and ongoing production. Many ethicists, including those at the Charlotte Lozier Institute, believe that using a fetal cell line for ongoing vaccine production is more ethically problematic than using a fetal cell line for design or confirmation. The design and confirmation steps use a limited number of fetal cells while the production stage is continuous.

Below is a chart that designates the known involvement of fetal cell lines in the six leading vaccine candidates:


(The red X indicates the utilization of an abortion-derived fetal cell line. The green check indicates the step was free of any utilization of an abortion derived fetal cell line.)

If, as a CMDA member, you would like to advocate for the development of a COVID-19 vaccine that is free from any ethical concerns, you may do so at our Freedom2Care Action Center. It should take you less than 30 seconds.


Articles and Personal Stories...

A Healthy Fear

By Al Weir, MD | April 7, 2020

One Person at a Time

By Amy Givler, MD | July 22, 2021

Trust in Public Health

By Jonathan Imbody | June 3, 2021

The World in Need

By Amy Givler, MD | May 27, 2021

On Faith and Fear

By Autumn Dawn Galbreath, MD, MBA | May 25, 2021

In the Midst of Uncertainty

By Krystal Mattox, DDS | March 30, 2020

A Touch of Compassion

By Jennifer Wade, DDS | May 5, 2020

Faith in Times of Uncertainty

By Sam Molind, DMD | May 19, 2020

COVID-19 Fact or Fiction?

By Jeffrey Barrows, DO, MA (Bioethics) | February 17, 2021

Navigating Vaccine Ethics

By Jonathan Imbody | January 7, 2021

Our Duty to COVID-19 Patients

By Eric F. Hussar, MD | December 30, 2020

First Do No Harm

By Autumn Dawn Galbreath, MD, MBA | November 24, 2020

Ethical Science at Warp Speed

By David Prentice, PhD | November 16, 2020

The Polarizing Pandemic

By Autumn Dawn Galbreath, MD, MBA | May 21, 2020

Thinking of Ultimate Things

By Amy Givler, MD | May 28, 2020

Responding to Anti-Christian Animus Revealed in the Pandemic

By Jonathan Imbody | June 4, 2020

Heroes, Wistfulness, Roles and Faithfulness

By Robert E. Cranston, MD, MA (Ethics) | June 11, 2020

What if Christians Led the Way Out of This? – Redefining our Freedom According to the Cross

By Christian Medical & Dental Associations® | July 22, 2020

A Vaccine Trial is Not a Trial: What Participating Looks Like

By Amy Givler, MD | September 24, 2020

Overcoming the Bombardment of COVID-19

By Doug Lindberg, MD | October 22, 2020

A Guide in the Middle of COVID-19

By Autumn Dawn Galbreath, MD, MBA | March 19, 2020

Anxious? Me, Too. How To Lean On God When Feelings Don’t Cooperate

By Amy Givler, MD | March 26, 2020

Keep FDA Safety Requirements and Nix Telemedicine Abortions

By Jonathan Imbody | April 30, 2020

Coronavirus Response Reveals Character of Governments

By Jonathan Imbody | April 2, 2020

COVID-19 Ramblings and Reflections

By Robert E. Cranston, MD, MA (Ethics) | April 9, 2020


  • Private Prayer from your CMDA Family

    Share your prayer requests privately with CMDA staff. These requests will only be shared within the CMDA staff and will not be made public.